Novel Psychoactive Substance Use and Psychological Trauma: A Multimethodological Analysis

References

• Abdulrahim, D., & Bowden-Jones, O. (2015). Guidance on the management of acute and chronic harms of club drugs and novel psychoactive substances. NEPTUNE.
   Google Scholar
• Alves, V. L., Gonçalves, J. L., Aguiar, J., Teixeira, H. M., & Câmara, J. S. (2020). The synthetic cannabinoids phenomenon: From structure to toxicological properties. A review. Critical Reviews in Toxicology, 50(5), 359–382. https://doi.org/10.1080/10408444.2020.1762539
   PubMed Web of Science ®Google Scholar
• Arbisi, P. A., Sellbom, M., & Ben-Porath, Y. S. (2008). Empirical correlates of the MMPI-2 Restructured Clinical (RC) Scales in psychiatric inpatients. Journal of Personality Assessment, 90(2), 122–128. https://doi.org/10.1080/00223890701845146
   PubMed Web of Science ®Google Scholar
• Archer, R. P. (2006). A perspective on the restructured clinical (RC) scale project. Journal of Personality Assessment, 87(2), 179–185. https://doi.org/10.1207/s15327752jpa8702_07
   PubMed Web of Science ®Google Scholar
• Bateman, A. W., & Fonagy, P. (2019). Handbook of mentalizing in mental health practice. American Psychiatric Publishing Inc.
   Google Scholar
• Butcher, J. N., Graham, J. R., Ben-Porath, Y. S., Tellegen, A., Dahlstrom, W. G., & Kaemmer, B. (2001). MMPI-2 (Minnesota Multiphasic Personality Inventory-2) manual for administration, scoring, and interpretation (translated by OS Hungary Tesztfejlesztő Kft., 2009 – Revised edition). OS Hungary Tesztfejlesztő Kft.
   Google Scholar
• Csák, R., Szécsi, J., Kassai, S., Márványkövi, F., & Rácz, J. (2020). New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary. The International Journal on Drug Policy, 85, 102639. https://doi.org/10.1016/j.drugpo.2019.102639
   PubMed Web of Science ®Google Scholar
• Csorba, J., Figeczki, T., Kiss, J., Medgyesi-Frank, K., & Péterfi, A. (2017). Intravénás szerhasználatból származó anyagmaradványok vizsgálata. In K. Felvinczi (Ed.), Változó képletek - Új(abb) szerek: Kihivások, mintázatok (pp. 87–103). L’Harmattan.
   Google Scholar
• Dvir, Y., Ford, J. D., Hill, M., & Frazier, J. A. (2014). Childhood maltreatment, emotional dysregulation, and psychiatric comorbidities. Harvard Review of Psychiatry, 22(3), 149–161. https://doi.org/10.1097/HRP.0000000000000014
   PubMed Web of Science ®Google Scholar
• Elekes, Z. (2014). Hungary’s neglected "alcohol problem": Alcohol drinking in a heavy consumer country. Substance Use & Misuse, 49(12), 1611–1618. https://doi.org/10.3109/10826084.2014.913396
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2016). Voluntary EMQ module for monitoring use of new (and not so new) psychoactive substances (NPS) in general adult population surveys and school surveys. EMCDDA.
   Google Scholar
• Finn, S. E., &Kamphuis, J. H. (2006). The MMPI-2 Restructured Clinical (RC) Scales and restraints to innovation, or "what have they done to my song?". Journal of Personality Assessment, 87(2), 202–210. https://doi.org/10.1207/s15327752jpa8702_10
   PubMed Web of Science ®Google Scholar
• Fonagy, P., Gergely, G. Y., Jurist, E. L., & Target, M. (2002). Affect regulation. Mentalization and the development of the self. Other Press.
   Google Scholar
• Forbey, J. D., & Ben-Porath, Y. S. (2008). Empirical correlates of the MMPI-2 Restructured Clinical (RC) Scales in a nonclinical setting. Journal of Personality Assessment, 90(2), 136–141. https://doi.org/10.1080/00223890701845161
   PubMed Web of Science ®Google Scholar
• Graham, J. R. (2000). MMPI-2: Assessing personality and psychopathology (3rd ed.). Oxford University Press.
   Google Scholar
• Greene, R. L. (2000). The MMPI-2: An interpretive manual (2nd ed.). Allyn & Bacon.
   Google Scholar
• Hien, D. A., Fitzpatrick, S., Saavedra, L. M., Ebrahimi, C. T., Norman, S. P., Tripp, J., Ruglass, L. M., Lopez-Castro, T., Killeen, T. K., Back, S. E., & Morgan-López, A. A. (2022). What’s in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders. European Journal of Psychotraumatology, 13(1), 2001191. https://doi.org/10.1080/20008198.2021.2001191
   PubMed Web of Science ®Google Scholar
• Higgins, K., O’Neill, N., O’Hara, L., Jordan, J. A., McCann, M., O’Neill, T., Clarke, M., O’Neill, T., Kelly, G., & Campbell, A. (2021). New psychoactives within polydrug use trajectories – Evidence from a mixed-method longitudinal study. Addiction (Abingdon, England), 116(9), 2454–2462. https://doi.org/10.1111/add.15422
   PubMed Web of Science ®Google Scholar
• Hungarian National Focal Point. (2020). 2020 National Report to the EMCDDA by the Reitox National Focal Point: Hungary. Reitox.
   Google Scholar
• Kaló, Z. (2020). Bevezetés a szerhasználó nők világába. L’Harmattan.
   Google Scholar
• Kaló, Z., & Felvinczi, K. (2017). Szakértői dilemmák és az ÚPSZ-használat észlelt mintázatai. In K. Felvinczi (Ed.), Változó képletek - Új(abb) szerek: Kihivások, mintázatok (pp. 103–125). L’Harmattan.
   Google Scholar
• Kaló, Z., Kassai, S., Rácz, J., & Van Hout, M. C. (2020). Synthetic cannabinoids (SCs) in metaphors: A metaphorical analysis of user experiences of synthetic cannabinoids in two countries. International Journal of Mental Health and Addiction, 18(1), 160–176. https://doi.org/10.1007/s11469-018-9970-0
   Web of Science ®Google Scholar
• Kassai, S., Pintér, J. N., Rácz, J., Böröndi, B., Tóth-Karikó, T., Kerekes, K., & Gyarmathy, V. A. (2017). Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis. Harm Reduction Journal, 14(1), 9. https://doi.org/10.1186/s12954-017-0138-1
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. The American Journal of Psychiatry, 142(11), 1259–1264. https://doi.org/10.1176/ajp.142.11.1259
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent application. Harvard Review of Psychiatry, 4(5), 231–244. https://doi.org/10.3109/10673229709030550
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. (2011). Addiction as a self-regulation disorder and the role of self-medication. Addiction (Abingdon, England), 108(4), 668–669. https://doi.org/10.1111/add.12004
   Web of Science ®Google Scholar
• Koski-Jännes, A. (2004). In search of a comprehensive model of addiction. In P. Rosenqvist, J. Blomqvist, A. Koski-Jännes, & L. Öjesjö (Eds.), Addiction and life course (pp. 49–67). NAD Publication 44.
   Google Scholar
• Kostiuk, L. M., & Fouts, G. T. (2002). Understanding of emotions and emotion regulation in adolescent females with conduct problems: A qualitative analysis. The Qualitative Report, 7(1), 1–15. https://doi.org/10.46743/2160-3715/2002.1985
   Google Scholar
• Martinotti, G., Lupi, M., Acciavatti, T., Cinosi, E., Santacroce, R., Signorelli, M. S., Bandini, L., Lisi, G., Quattrone, D., Ciambrone, P., Aguglia, A., Pinna, F., Calò, S., Janiri, L., & di Giannantonio, M. (2014). Novel psychoactive substances in young adults with and without psychiatric comorbidities. BioMed Research International, 2014, 815424. https://doi.org/10.1155/2014/815424
   PubMed Web of Science ®Google Scholar
• McKernan, L. C., Nash, M. R., Gottdiener, W. H., Anderson, S. E., Lambert, W. E., & Carr, E. R. (2015). Further evidence of self-medication: Personality factors influencing drug choice in substance use disorders. Psychodynamic Psychiatry, 43(2), 243–275. https://doi.org/10.1521/pdps.2015.43.2.243
   PubMedGoogle Scholar
• MMPI Info. (n.d.a). Restructured Clinical (RC) Scales. https://www.mmpi-info.com/restructured-clinical-rc-scales
   Google Scholar
• MMPI Info. (n.d.b). Supplementary Scales. https://www.mmpi-info.com/supplementary-scales
   Google Scholar
• Nagulendran, A., & Jobson, L. (2020). Exploring cultural differences in the use of emotion regulation strategies in posttraumatic stress disorder. European Journal of Psychotraumatology, 11(1), 1729033. https://doi.org/10.1080/20008198.2020.1729033
   PubMed Web of Science ®Google Scholar
• Nichols, D. S. (2001). Essentials of MMPI-2 assessment. John Wiley & Sons.
   Google Scholar
• Osberg, T. M., Haseley, E. N., & Kamas, M. M. (2008). The MMPI-2 clinical scales and restructured clinical (RC) scales: Comparative psychometric properties and relative diagnostic efficiency in young adults. Journal of Personality Assessment, 90(1), 81–92. https://doi.org/10.1080/00223890701693801
   PubMed Web of Science ®Google Scholar
• Rácz, J., Csák, R., Tóth, K. T., Tóth, E., Rozmán, K., & Gyarmathy, V. A. (2016). Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014. Drug and Alcohol Dependence, 158(1), 154–158. https://doi.org/10.1016/j.drugalcdep.2015.10.034
   PubMedGoogle Scholar
• Roberts, N. P. (2021). Development of expert recommendations for the treatment of PTSD with comorbid substance use disorder. European Journal of Psychotraumatology, 12(sup1). https://doi.org/10.1080/20008198.2020.1866419
   Google Scholar
• Roberts, N. P., Roberts, P. A., Jones, N., & Bisson, J. I. (2015). Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis. Clinical Psychology Review, 38, 25–38. https://doi.org/10.1016/j.cpr.2015.02.007
   PubMed Web of Science ®Google Scholar
• Schifano, F., Orsolini, L., Papanti, D. G., & Corkery, J. M. (2015). Novel psychoactive substances of interest for psychiatry. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 14(1), 15–26. https://doi.org/10.1002/wps.20174
   PubMed Web of Science ®Google Scholar
• Schorr, M. T., Tietbohl-Santos, B., de Oliveira, L. M., Terra, L., de Borba Telles, L. E., & Hauck, S. (2020). Association between different types of childhood trauma and parental bonding with antisocial traits in adulthood: A systematic review. Child Abuse & Neglect, 107, 104621. https://doi.org/10.1016/j.chiabu.2020.104621
   PubMed Web of Science ®Google Scholar
• Sellbom, M., & Ben-Porath, Y. S. (2005). Mapping the MMPI-2 Restructured Clinical scales onto normal personality traits: Evidence of construct validity. Journal of Personality Assessment, 85(2), 179–187. https://doi.org/10.1207/s15327752jpa8502_10
   PubMed Web of Science ®Google Scholar
• Sellbom, M., Ben-Porath, Y. S., Baum, L. J., Erez, E., & Gregory, C. (2008). Predictive validity of the MMPI-2 Restructured Clinical (RC) Scales in a batterers’ intervention program. Journal of Personality Assessment, 90(2), 129–135. https://doi.org/10.1080/00223890701845153
   PubMed Web of Science ®Google Scholar
• Sellbom, M., Graham, J. R., & Schenk, P. W. (2006). Incremental validity of the MMPI-2 Restructured Clinical (RC) scales in a private practice sample. Journal of Personality Assessment, 86(2), 196–205. https://doi.org/10.1207/s15327752jpa8602_09
   PubMed Web of Science ®Google Scholar
• Tamama, K., & Lynch, M. J. (2020). Newly emerging drugs of abuse. In M. Nader, & Y. Hurd (Eds.), Substance use disorders. From etiology to treatment (pp. 463–502). Springer. https://doi.org/10.1007/164_2019_260
   Google Scholar
• Tellegen, A., Ben-Porath, Y. S., McNulty, J. L., Arbisi, P. A., Graham, J. R., & Kaemmer, B. (2003). MMPI-2 restructured clinical (RC) scales: Development, validation, and interpretation. University of Minnesota Press.
   Google Scholar
• United Nations Office on Drugs and Crime. (2013). The challenge of new psychoactive substances. UNODC.
   Google Scholar
• Valeriani, G., Corazza, O., Bersani, F. S., Melcore, C., Metastasio, A., Bersani, G., & Schifano, F. (2015). Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics’ use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms. Human Psychopharmacology, 30(4), 249–254. https://doi.org/10.1002/hup.2431
   PubMed Web of Science ®Google Scholar
• Van den Brink, W. (2015). Substance use disorders, trauma, and PTSD. European Journal of Psychotraumatology, 6(1). https://doi.org/10.3402/ejpt.v6.27632
   Google Scholar
• Van Hout, M. C., Benschop, A., Bujalski, M., Dąbrowska, K., Demetrovics, Z., Felvinczi, K., Hearne, E., Henriques, S., Kaló, Z., Kamphausen, G., Korf, D., Silva, J. P., Wieczorek, Ł., & Werse, B. (2018). Health and social problems associated with recent Novel Psychoactive Substance (NPS) use amongst marginalised, nightlife and online users in six European countries. International Journal of Mental Health and Addiction, 16(2), 480–495. https://doi.org/10.1007/s11469-017-9824-1
   PubMed Web of Science ®Google Scholar
• Werb, D., Richardson, C., Buxton, J., Shoveller, J., Wood, E., & Kerr, T. (2015). Development of a brief substance use sensation seeking scale: Validation and prediction of injection-related behaviors. AIDS and Behavior, 19(2), 352–361. https://doi.org/10.1007/s10461-014-0875-z
   PubMed Web of Science ®Google Scholar
• Wolf, E. J., Miller, M. W., Orazem, R. J., Weierich, M. R., Castillo, D. T., Milford, J., Kaloupek, D. G., & Keane, T. M. (2008). The MMPI-2 restructured clinical scales in the assessment of posttraumatic stress disorder and comorbid disorders. Psychological Assessment, 20(4), 327–340. https://doi.org/10.1037/a001
   PubMed Web of Science ®Google Scholar